Next Generation News and Research

RSS

Onyx Pharmaceuticals announces presentations evaluating carfilzomib for multiple myeloma at 46th ASCO

Onyx Pharmaceuticals, Inc. today announced the presentation of several studies evaluating carfilzomib, a selective, next-generation proteasome inhibitor, at the 46th American Society of Clinical Oncology (ASCO) Annual Meeting, June 4-8, 2010 in Chicago, IL.

21 May 2010

Studies identify new chemical compounds that could lead to development of new malaria drugs

Researchers have identified thousands of chemical compounds that could be used to develop new malaria drugs, two studies published in the journal Nature on Wednesday show, the Wall Street Journal reports.

21 May 2010

St. Jude Medical to acquire LightLab for $90M in cash

St. Jude Medical, Inc., a global medical device company, and LightLab Imaging, Inc. today announced a definitive agreement under which St. Jude Medical will acquire LightLab, a subsidiary of Goodman Co., Ltd. for approximately $90 million in cash.

20 May 2010

Health care high school to open in Chicago

Crain's Chicago Business reports that, in the fall, the city will open its "first charter high school specializing in health care, a move local hospitals hope will help relieve chronic workforce shortages. ... Juniors and seniors will be able to earn credits by shadowing hospital workers and interning as assistant nurses and in other professions."

20 May 2010

Curis announces inclusion in NASDAQ Biotechnology Index

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that it has been selected for addition to the NASDAQ Biotechnology Index (NBI), which will become effective prior to market open on Monday, May 24, 2010.

19 May 2010

PrimeWire PRESTIGE Pressure Guide Wire receives 510(k) clearance, CE Mark approval

Volcano Corporation announced today it received both 510(k) clearance and CE Mark approval for its PrimeWire PRESTIGE Pressure Guide Wire for use with patients who have both single-vessel and multi-vessel disease. This next generation pressure wire is compatible with Volcano's full suite of integrated multi-modality consoles and stand-alone physiology systems as well as various hemodynamic monitoring systems.

19 May 2010

Experts accelerate discovery and development of new TB drugs: Lancet article

According to a paper published today in the Lancet, there is unprecedented progress in the development of the global tuberculosis drug pipeline with 10 drug candidates currently in clinical development. The paper was written by a team of renowned international experts led by Zhenkun Ma, Ph.D., Chief Scientific Officer for the TB Alliance, a not-for-profit organization accelerating the discovery and development of new TB drugs.

19 May 2010

Molecular Devices' foundational planar patch-clamp patent upheld by European Patent Office

Molecular Devices today announced that European Patent Office (EPO) has upheld Molecular Devices foundational planar patch-clamp patent (EP No 1 040 349 B1). The board will issue a written decision to this effect in the near future. The ruling will be the final determination of the EPO and cannot be appealed.

19 May 2010

Genesys HTA System receives FDA approval for treatment of menorrhagia

Boston Scientific Corporation today announced U.S. Food and Drug Administration approval of its Genesys HTA System for the treatment of menorrhagia. The Genesys HTA System is a next-generation endometrial ablation system designed to ablate the endometrial lining of the uterus in premenopausal women with menorrhagia.

18 May 2010

FDA grants LensAR Laser System 510(k) clearance for use in anterior capsulotomy during cataract surgery

LensAR, Inc., the leading developer of next generation laser technology for cataract surgery and presbyopia, today announced that the company has received 510(k) clearance from the FDA for use of the LensAR Laser System for anterior capsulotomy during cataract surgery.

18 May 2010

Applied Biosystems Identifiler Direct and Identifiler Plus kits approved for forensic DNA laboratories

Life Technologies Corporation today announced that its Applied Biosystems Identifiler Direct and Identifiler Plus forensic kits have been approved by the United States Federal Bureau of Investigation for use by laboratories generating DNA profiles for inclusion in the National DNA Index System CODIS Database.

18 May 2010

Caliper to sell RapidTrace solid phase extraction and TurboVap evaporation product lines to Biotage for $16.5M

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery and life sciences research, today announced that it reached an agreement to sell its RapidTrace® solid phase extraction and TurboVap® evaporation product lines to Biotage AB for $16.5 million in cash.

18 May 2010

PositiveID announces early completion of iGlucose system prototype development

PositiveID Corporation announced today that it has completed development of the initial prototype of its iGlucose system, creating a small cradle that connects to any data-capable glucose meter to automatically communicate a diabetic's blood sugar readings to the iGlucose online database.

18 May 2010

Inovio Pharmaceuticals first-quarter net loss attributable to common stockholders decreases to $2.3M

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2010.

18 May 2010

Echo Therapeutics first-quarter net loss increases to $1.9 million

Echo Therapeutics, Inc., a company developing its needle-free Symphony™ tCGM System as a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system and its Prelude™ SkinPrep System for transdermal drug delivery, today announced financial results for the period ended March 31, 2010.

18 May 2010

152 research and training grants awarded to researchers at 93 institutions nationwide

The American Cancer Society, the largest non-government, not-for-profit funding source of cancer research in the United States, has awarded 152 new national research and training grants totaling $50,717,000 in the first of two grants cycles for 2010. The grants, primarily to early career researchers, cover a broad range of investigator-initiated ideas at 93 institutions nationwide, from whether cadmium exposure increases the risk of endometrial cancer, to studies of plant and bacterial-bourne compounds, to a study on a protein called survivin that could lead to novel drugs targeting prostate cancer.

18 May 2010

U.S. Patent and Trademark Office grants patent to Historx's AQUA technology

HistoRx , Inc., announced today that the U.S. Patent and Trademark Office has granted a patent protecting the company's methods for determining a cancer patient's prognosis based on sub-cellular localization of biomarkers.

15 May 2010

IVAX Diagnostics first-quarter net revenues decline 1.4% to $4,655,000

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended March 31, 2010.

14 May 2010

Rensselaer professor selected to receive NSF CAREER Award

David T. Corr, assistant professor in the Department of Biomedical Engineering at Rensselaer Polytechnic Institute, has won a Faculty Early Career Development Award from the National Science Foundation.

14 May 2010

Viking Systems announces positive response to 3DHD camera-display combination at Hospital Build Asia 2010

Viking Systems, Inc. today announced an overwhelmingly positive response to the demonstration of the 3DHD combination of Viking's cameras with Sony's 3DHD display by those who had the opportunity to experience it earlier this week in Singapore at Hospital Build Asia 2010 Exhibition and Congress.

14 May 2010

Next Generation News and Research

Onyx Pharmaceuticals announces presentations evaluating carfilzomib for multiple myeloma at 46th ASCO

Studies identify new chemical compounds that could lead to development of new malaria drugs

St. Jude Medical to acquire LightLab for $90M in cash

Health care high school to open in Chicago

Curis announces inclusion in NASDAQ Biotechnology Index

PrimeWire PRESTIGE Pressure Guide Wire receives 510(k) clearance, CE Mark approval

Experts accelerate discovery and development of new TB drugs: Lancet article

Molecular Devices' foundational planar patch-clamp patent upheld by European Patent Office

Genesys HTA System receives FDA approval for treatment of menorrhagia

FDA grants LensAR Laser System 510(k) clearance for use in anterior capsulotomy during cataract surgery

Applied Biosystems Identifiler Direct and Identifiler Plus kits approved for forensic DNA laboratories

Caliper to sell RapidTrace solid phase extraction and TurboVap evaporation product lines to Biotage for $16.5M

PositiveID announces early completion of iGlucose system prototype development

Inovio Pharmaceuticals first-quarter net loss attributable to common stockholders decreases to $2.3M

Echo Therapeutics first-quarter net loss increases to $1.9 million

152 research and training grants awarded to researchers at 93 institutions nationwide

U.S. Patent and Trademark Office grants patent to Historx's AQUA technology

IVAX Diagnostics first-quarter net revenues decline 1.4% to $4,655,000

Rensselaer professor selected to receive NSF CAREER Award

Viking Systems announces positive response to 3DHD camera-display combination at Hospital Build Asia 2010

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News